Provided by Tiger Fintech (Singapore) Pte. Ltd.

Goldman Sachs Holdings

1,696.92
-3.5620-0.21%
Number of Gainers:48
Number of Losers:49
Number of Flat:- -
PE:- -
High:1,700.60
Open:1,700.60
Low:1,680.23
Close:1,700.49
Loading ...

Oracle Health to Collaborate With Cleveland Clinic, G42 for AI Health Care Platform

MT Newswires Live
·
16 May

Walmart Price Hikes ‘Shouldn’t Have Been Surprising,’ Says RBC Analyst

TIPRANKS
·
16 May

Bullish Outlook on Duolingo: Growth Potential in the Language Learning Industry

TIPRANKS
·
16 May

Why Astera Labs Stock Was on Fire This Week

Motley Fool
·
16 May

Tesla Names Chipotle Executive John R. Hartung to Board

MT Newswires Live
·
16 May

UnitedHealth call buyer realizes 21% same-day gains

TIPRANKS
·
16 May

How the S&P 500 Can Be Your New Best Friend

TIPRANKS
·
16 May

Qualcomm Partners With e& on 5G and Edge AI Development in UAE

MT Newswires Live
·
16 May

Bristol-Myers Squibb Receives European Approval for Opdivo Regimen to Treat Lung Cancer

MT Newswires Live
·
16 May

Anthony Scaramucci Once Dubbed Bitcoin The 'Berkshire Hathaway Of The 21st Century'—Since Then, It Has Outpaced Warren Buffett's Stock By A Wide Margin

Benzinga
·
16 May

Albany International (AIN) Receives a Hold from J.P. Morgan

TIPRANKS
·
16 May

Fortive (FTV): New Buy Recommendation for This Technology Giant

TIPRANKS
·
16 May

Otis Worldwide (OTIS) Gets a Hold from J.P. Morgan

TIPRANKS
·
16 May

Vertiv Holdings (VRT) Receives a Buy from J.P. Morgan

TIPRANKS
·
16 May

J.P. Morgan Remains a Hold on Rockwell Automation (ROK)

TIPRANKS
·
16 May

Hubbell B (HUBB) Gets a Hold from J.P. Morgan

TIPRANKS
·
16 May

Intuit’s Growth Potential and Resilience: A Buy Recommendation by Daniel Jester

TIPRANKS
·
16 May

Workday’s Strategic Growth and Resilience Amidst Economic Uncertainties: A Buy Recommendation

TIPRANKS
·
16 May

BRIEF-Bristol Myers Squibb Receives European Commission Approval For Perioperative Regimen Of Neoadjuvant Opdivo(Nivolumab) And Chemotherapy Followed By Adjuvant Opdivo For Resectable, High-Risk Non-Small Cell Lung Cancer With Pd-L1 Expression ≥1%

Reuters
·
16 May

Press Release: Canopy Growth to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 30, 2025

Dow Jones
·
16 May